loading

Vtv Therapeutics Inc Azioni (VTVT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
1.00
- - - -
Operating Expenses
40.79%
6.627
4.707 5.368 8.00 7.427
Benefits Costs and Expenses
6.919
- - - -
Costs And Expenses
6.919
- - - -
Operating Income/Loss
19.55%
-5.627
-4.707 -5.368 -8.00 -7.427
Income/Loss From Continuing Operations Before Tax
33.28%
-5.919
-4.441 -8.54 -7.211 -5.774
Income Tax Expense/Benefit
0.10
- - - -
Income/Loss From Continuing Operations After Tax
35.53%
-6.019
-4.441 -8.54 -7.211 -5.774
Net Income/Loss
35.53%
-6.019
-4.441 -8.54 -7.211 -5.774
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
19.83%
-1.154
-0.963 -1.886 -1.592 -1.275
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Capitalizzazione:     |  Volume (24 ore):